Dexrazoxane Preserves Cardiac Function in Pediatric Leukemia
Beneficial for patients with AML receiving anthracyclines, with no impact on event-free, overall survival
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.